193 related articles for article (PubMed ID: 18456503)
21. Production cross sections of niobium and tantalum isotopes in proton-induced reactions on (nat)Zr and (nat)Hf up to 14 MeV.
Murakami M; Haba H; Goto S; Kanaya J; Kudo H
Appl Radiat Isot; 2014 Aug; 90():149-57. PubMed ID: 24747531
[TBL] [Abstract][Full Text] [Related]
22. Predicting the yield of (177)Lu radionuclide produced by the cyclic irradiation technique.
Odame Duodu G; Akaho EH; Serfor-Armah Y; Nyarko BJ; Afi Achoribo E
Appl Radiat Isot; 2011 Mar; 69(3):588-93. PubMed ID: 21177113
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
Chen J; Linder KE; Cagnolini A; Metcalfe E; Raju N; Tweedle MF; Swenson RE
Appl Radiat Isot; 2008 Apr; 66(4):497-505. PubMed ID: 18178448
[TBL] [Abstract][Full Text] [Related]
24. Measurement of the 177Lu half-life.
Pommé S; Paepen J; Altzitzoglou T; Van Ammel R; Yeltepe E
Appl Radiat Isot; 2011 Sep; 69(9):1267-73. PubMed ID: 21550813
[TBL] [Abstract][Full Text] [Related]
25. Study of cross sections for (n,p) reactions on Hf, Ta and W isotopes.
Yiğit M
Appl Radiat Isot; 2021 Aug; 174():109779. PubMed ID: 34044314
[TBL] [Abstract][Full Text] [Related]
26. Radiochemical separation of no-carrier-added 177Lu as produced via the 176Yb(n,gamma)177Yb-->177Lu process.
Lebedev NA; Novgorodov AF; Misiak R; Brockmann J; Rösch F
Appl Radiat Isot; 2000 Sep; 53(3):421-5. PubMed ID: 10972147
[TBL] [Abstract][Full Text] [Related]
27. Absolute peptide quantification by lutetium labeling and nanoHPLC-ICPMS with isotope dilution analysis.
Rappel C; Schaumlöffel D
Anal Chem; 2009 Jan; 81(1):385-93. PubMed ID: 19117464
[TBL] [Abstract][Full Text] [Related]
28. Cross-section measurements and nuclear model calculation for proton induced nuclear reaction on zirconium.
Al-Abyad M; Abdel-Hamid AS; Tárkányi F; Ditrói F; Takács S; Seddik U; Bashter II
Appl Radiat Isot; 2012 Jan; 70(1):257-62. PubMed ID: 21865049
[TBL] [Abstract][Full Text] [Related]
29. Total nucleon-nucleus reaction cross sections calculated in the frame of the cascade model.
Sannikov AV; Savitskaya EN
Radiat Prot Dosimetry; 2004; 110(1-4):27-31. PubMed ID: 15353617
[TBL] [Abstract][Full Text] [Related]
30. Investigation of production of the therapeutic radioisotope 165 Er by proton induced reactions on erbium in comparison with other production routes.
Tárkányi F; Takács S; Hermanne A; Ditrói F; Király B; Baba M; Ohtsuki T; Kovalev SF; Ignatyuk AV
Appl Radiat Isot; 2009 Feb; 67(2):243-7. PubMed ID: 19059787
[TBL] [Abstract][Full Text] [Related]
31. Theoretical modeling of yields for proton-induced reactions on natural and enriched molybdenum targets.
Celler A; Hou X; Bénard F; Ruth T
Phys Med Biol; 2011 Sep; 56(17):5469-84. PubMed ID: 21813960
[TBL] [Abstract][Full Text] [Related]
32. Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu(n,gamma)177Lu.
Dvorakova Z; Henkelmann R; Lin X; Türler A; Gerstenberg H
Appl Radiat Isot; 2008 Feb; 66(2):147-51. PubMed ID: 17900914
[TBL] [Abstract][Full Text] [Related]
33.
Kirischuk VI; Ageev VA; Savrasov AM; Strilchuk MV; Zheltonozhsky VO
Appl Radiat Isot; 2023 Aug; 198():110864. PubMed ID: 37229806
[No Abstract] [Full Text] [Related]
34. Production of thulium-167 for medical use by irradiation of lutetium, hafnium, tantalum and tungsten with 590-MeV protons.
Scholz KL; Sodd VJ; Blue JW
Int J Appl Radiat Isot; 1976; 27(5-6):263-6. PubMed ID: 955726
[No Abstract] [Full Text] [Related]
35. Anaerobic 90Y- and 177Lu-labeling of a DOTA-conjugated nonpeptide vitronectin receptor antagonist.
Liu S; Harris TD; Ellars CE; Edwards DS
Bioconjug Chem; 2003; 14(5):1030-7. PubMed ID: 13129408
[TBL] [Abstract][Full Text] [Related]
36. High yield production of the medical radioisotope 167Tm by the 167Er(d,2n) reaction.
Hermanne A; Rebeles RA; Tárkányi F; Takács S; Spahn I; Ignatyuk AV
Appl Radiat Isot; 2011 Feb; 69(2):475-81. PubMed ID: 20971015
[TBL] [Abstract][Full Text] [Related]
37. Production logistics of 177Lu for radionuclide therapy.
Pillai MR; Chakraborty S; Das T; Venkatesh M; Ramamoorthy N
Appl Radiat Isot; 2003; 59(2-3):109-18. PubMed ID: 12941498
[TBL] [Abstract][Full Text] [Related]
38. Results of an international comparison for the activity measurement of 177Lu.
Zimmerman BE; Altzitzoglou T; Antohe A; Arinc A; Bakhshandeiar E; Bergeron DE; Bignell L; Bobin C; Capogni M; Cessna JT; Cozzella ML; da Silva CJ; De Felice P; Dias MS; Dziel T; Fazio A; Fitzgerald R; Iwahara A; Jaubert F; Johansson L; Keightley J; Koskinas MF; Kossert K; Lubbe J; Luca A; Mo L; Nähle O; Ott O; Paepen J; Pommé S; Sahagia M; Simpson BR; Silva FF; van Ammel R; van Staden MJ; van Wyngaardt WM; Yamazaki IM
Appl Radiat Isot; 2012 Sep; 70(9):1825-30. PubMed ID: 22445396
[TBL] [Abstract][Full Text] [Related]
39. Study of activation cross sections of proton induced reactions on barium: Production of 131Ba-->131Cs.
Tárkányi F; Ditrói F; Király B; Takács S; Hermanne A; Yamazaki H; Baba M; Mohammadi A; Ignatyuk AV
Appl Radiat Isot; 2010 Oct; 68(10):1869-77. PubMed ID: 20338770
[TBL] [Abstract][Full Text] [Related]
40. Cross-sections of the reaction 232Th(p,3n)230Pa for production of 230U for targeted alpha therapy.
Morgenstern A; Apostolidis C; Bruchertseifer F; Capote R; Gouder T; Simonelli F; Sin M; Abbas K
Appl Radiat Isot; 2008 Oct; 66(10):1275-80. PubMed ID: 18374585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
